Wade Ackerman is a partner in Covington’s Food, Drug, and Device practice. Until June 2016, Mr. Ackerman served as Senior FDA Counsel to the U.S. Senate Health Education, Labor & Pensions Committee where he was involved in legislative initiatives, oversight hearings, and other Senate activities concerning the FDA and the Federal Food, Drug, and Cosmetic Act. He worked with the FDA and other stakeholders as Congress examined legislative reforms in key areas, including drug and device innovation, diagnostics, health software, and combination products. Through private practice and roles at the FDA and on the Hill, Mr. Ackerman developed a unique insight into the legal and regulatory issues surrounding the marketing of FDA-regulated products.